Navigation Links
Aware, Inc. Reports Fourth Quarter and 2007 Financial Results
Date:2/12/2008

al imaging. Aware is a publicly held company (Nasdaq: AWRE) based in Bedford, Massachusetts. http://www.aware.com

Safe Harbor Warning

Portions of this release contain forward-looking statements regarding future events and are subject to risks and uncertainties, such as estimates or projections of future revenue and earnings and the growth of the DSL and biometrics markets. Aware wishes to caution you that there are factors that could cause actual results to differ materially from the results indicated by such statements. The DSL factors include, but are not limited to: we have a unique business model, our quarterly results are difficult to predict, we depend on a limited number of licensees, we derive a significant amount of revenue from a small number of customers, we depend on equipment companies to incorporate our technology into their products, we face intense competition from other DSL vendors, DSL technology competes with other technologies for broadband access, and our business is subject to rapid technological change. The biometric factors include, but are not limited to: market acceptance of our biometric products, changes in contracting practices of government or law enforcement agencies, announcements or introductions of new products by our competitors, delays, failures or problems in our biometric products, delays in the adoption of new industry biometric standards, and competitive pressures resulting in lower software product revenues. We refer you to the documents Aware files from time to time with the Securities and Exchange Commission, specifically the section titled Risk Factors in our annual report on Form 10-K for the fiscal year ended December 31, 2006 and other r
'/>"/>

SOURCE Aware, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology news :

1. Aware, Inc. Announces Richard Moberg to Return as CFO
2. Aware, Inc. Introduces Biometrics Software for Tenprint Autocapture
3. MIT reports new twist in microRNA biology
4. Drug aimed at 2 bioterror agents blocks live viral infection, Weill Cornell team reports
5. UVA reports surprising findings related to myotonic muscular dystrophy
6. Rong Li Lab reports protein interactions of MAP kinase signaling pathway
7. WHRC releases 4 key reports
8. BIO-key Reports Third Quarter 2007 Results
9. Emory paleontologist reports discovery of carnivorous dinosaur tracks in Australia
10. Communication Intelligence Corporation Reports Second Quarter 2007 Financial Results
11. BIO-key Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)The body is a battle zone. Cells constantly compete with one another for space and dominance. Though the manner in which some cells win this competition is well known to be the survival of the fittest
(Date:12/4/2009)The electroencephalogram (EEG) is widely used by physicians and scientists to study brain function and to diagnose neurological disorders. However, it has remained largely unknown whether the electrod
(Date:12/3/2009)In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to dege
Breaking Biology News(10 mins):Stem cells battle for space 2How to read brain activity? 2Papillomavirus silences innate immune response 2Urban Caucus Chair Urges Caucus Members to Get the Job Done for Health Care Reform 51283 1Urban Caucus Chair Urges Caucus Members to Get the Job Done for Health Care Reform 51283 2VA Advisory Committee on Women Veterans Visits Dallas 51281 1VA Advisory Committee on Women Veterans Visits Dallas 51281 2RealMed Receives 231 Ranking in the KLAS 2009 Ambulatory Clearinghouse Services Report 51279 1RealMed Receives 231 Ranking in the KLAS 2009 Ambulatory Clearinghouse Services Report 51279 2
...ecember 5, 2007, 2007) In the wake of a study tha...y by Cross River gorillas to ward off threats by h... today new field surveys to better protect this mo...arlier this year in the Journal of Primatology, fo...and clumps of grass when threatened by people. Go...
...5 December 2007 - If you needed to see a specimen ..., would you know where to look? Finding a natural...icular time or place right now is mostly a matter ...n Facility (GBIF), Biodiversity Information Standa...are paving the way for more effective internationa...
... After an injury, the body grows new blood vessels...growth causes problems, as when new blood vessels ... blindness if not treated. , A protein called CIB...orth Carolina at Chapel Hill School of Medicine ap...d vessel growth, offering a target for drug treatm...
Other Biology News:GBIF making the search for biodiversity research resources easier 2Protein controls blood vessel formation, offers new drug target 2
(Date:12/2/2009)CAMBRIDGE, Mass., Dec. 2 TechConnect World, an event bringing together the leaders in technology development and product integration in cleantech, nanotech, biotech and MEMS, announced the December 1
(Date:12/2/2009)SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans. ,
(Date:12/2/2009)NANJING, China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,("Simcere" or the "Company") (NYSE: SCR ), a leading pharmaceutical company,specializing in the development, manufacturing, a
(Date:12/2/2009)SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is going through,extraordinary times; markets are in turmoil and uncertainty is part of many,businesses and industries. It turns out that the pharma ind
Breaking Biology Technology:Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
... International,Corporation (Nasdaq: PRXL ) announ...hief Executive Officer, will be presenting at the ...e Four Seasons Hotel in Boston,on Friday, Septembe...entation can be accessed through the "Investor Rel... http://www.PAREXEL.com and a replay of the,prese...
...Veteran Richard Franco and Entrepreneur Anthony ...ctors, IRVINE, Calif., Sept. 5 NeoMatrix, develo...omatic, noninvasive test designed to,identify brea...as closed a,Series C round of equity financing. Th... of the HALO System, which is designed to test asy...
...a Pharmaceuticals,Inc. (Nasdaq: ARNA ) announced ...the Bear Stearns 20th Annual Healthcare Conference...12:30 p.m. Pacific Time) at the Grand,Hyatt Hotel ... Chief,Executive Officer, is scheduled to provide ...al development and discovery programs. A live aud...
Other Biology Technology:PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference 2NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test 2NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test 3NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test 4Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference 3
Anti-Human Amyloid beta [1-16] Monoclonal Antibody, Unconjugated, Clone 6E10 from Cell Sciences
Anti-HES-1 Antibody, Unconjugated from CHEMICON
Chicken Anti-Human Uridine Phosphorylase 1 Polyclonal Antibody, Unconjugated from Abcam
Anti-Presenilin-1, N-terminus Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: